Trading Members of the Exchange are hereby informed that effective from September 30, 2025, the equity shares of Aptus Pharma Ltd (Scrip Code: 544529) are listed and admitted to dealings ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aptus Pharma Ltd (Scrip Code: 544529) has been formally listed and admitted to dealings on the BSE effective September 30, 2025. The company has joined the exchange with its equity shares now available for trading. This marks the stock's debut and the start of regular market activity for investors. No specific IPO details, pricing, or anchor information are provided in the excerpt.
This is a standard new listing notice, making Aptus Pharma shares available for buying and selling on the BSE from the stated date. Shareholders who held shares pre-listing can now trade them, and new investors gain access to the stock.